GlassScriptPhysician profile
James Bonnen
NPI 1003812264
$1,281.82
in general payments reported to CMS, 2019-2025
11 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.79 · 2021: $238 · 2023: $224 · 2024: $613 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $441.92 | 2023-2025 | Swiftset, Percept PC Brainsense, Activa PC |
| Insightec,INC | $303.15 | 2021-2024 | Exablate |
| Providence Medical Technology, INC. | $223.67 | 2021-2024 | |
| Stryker Corporation | $82.83 | 2024 | Everest Spinal System |
| Abbott Laboratories | $68.61 | 2023 | Eterna, Infinity, Prodigy |
| Zimmer Biomet Holdings, INC. | $43.37 | 2019 | |
| Ibsa Pharma INC. | $34.44 | 2023-2024 | Tirosint, Licart, Tirosint |
| Baxter Healthcare | $34.26 | 2019 | |
| Heron Therapeutics, INC. | $20.55 | 2024 | Zynrelef |
| Medinc of Texas | $17.86 | 2024 | |
| Arteriocyte Medical Systems, INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bonnen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.